Rp-C to progesterone alone; Ra, uterine enzyme response to combination of progesterone and anthrarufin; C, control level. In the present study, anthrarufin, a derivative related to anthraquinone, showed an antiprogestational action, although anthraquinone and anthrone were inactive. In this respect, the hydroxyl structure of anthrarufin is needed for the response and may exhibit the inhibitory activity on the endometrial progestation. The question arises whether anthrarufin itself is in vivo a potent progestational inhibitor on injection. It seems likely that in vivo conversion product of anthrarufin is res ponsible for the progestational inhibition and presumably this conversion takes place in the guts or in the liver. The present study, however, does not permit any explanation as to the site of anthrarufin action and the mechanism of this antagonism. It was not investigated whether the action of this substance is a direct one on the endometrium or is due to neutralization or inactivation by an thrarufin of progesterone present in the body.
